Suppr超能文献

腺苷在他汀类药物诱导的细胞外信号调节激酶1/2(ERK1/2)、蛋白激酶B(Akt)和内皮型一氧化氮合酶(eNOS)磷酸化中的核心作用。

The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.

作者信息

Merla Ramanna, Ye Yumei, Lin Yu, Manickavasagam Saraswathy, Huang Ming-He, Perez-Polo Regino J, Uretsky Barry F, Birnbaum Yochai

机构信息

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555-0553, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1918-28. doi: 10.1152/ajpheart.00416.2007. Epub 2007 Jul 6.

Abstract

Statins activate phosphatidylinositol-3-kinase, which activates ecto-5'-nucleotidase and phosphorylates 3-phosphoinositide-dependent kinase-1 (PDK-1). Phosphorylated (P-)PDK-1 phosphorylates Akt, which phosphorylates endothelial nitric oxide synthase (eNOS). We asked if the blockade of adenosine receptors (A(1), A(2A), A(2B), or A(3) receptors) could attenuate the induction of Akt and eNOS by atorvastatin (ATV) and whether ERK1/2 is involved in the ATV regulation of Akt and eNOS. In protocol 1, mice received intraperitoneal ATV, theophylline (TH), ATV + TH, or vehicle. In protocol 2, mice received intraperitoneal injections of ATV, U0126 (an ERK1/2 inhibitor), ATV + U0126, or vehicle; 8 h later, hearts were assessed by immunoblot analysis. In protocol 3, mice received intraperitoneal ATV alone or with 8-sulfophenyltheophylline (SPT); 1, 3, and 6 h after injection, hearts were assessed by immunoblot analysis. In protocol 4, mice received intraperitoneal ATV alone or with SPT, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), 1,3,7-trimethyl-8-(3-chlorostyryl)xanthine (CSC), alloxazine, or MRS-1523; 3 h after injection, hearts were assessed by immunoblot analysis. ATV increased P-ERK, P-PDK-1, Ser(473) P-Akt, Thr(308) P-Akt, and P-eNOS levels. TH blocked ATV-induced increases in P-ERK, Ser(473) P-Akt, Thr(308) P-Akt, and P-eNOS levels without affecting the induction of P-PDK-1 by ATV. U0126 blocked the ATV induction of Ser(473) P-Akt and Thr(308) P-Akt while attenuating the induction of P-eNOS. A detectable increase in P-ERK, Ser(473) P-Akt and P-eNOS was seen 3 and 6 h after injection but not at 1 h. DPCPX, CSC, and alloxazine partially blocked the ATV induction of P-ERK, Ser(473) P-Akt, and P-eNOS. In conclusion, blockade of adenosine A(1), A(2A), and A(2B) receptors but not A(3) receptors inhibited the induction of Akt and eNOS by statins. Adenosine was required for ERK1/2 activation by statins, which resulted in Akt and eNOS phosphorylation.

摘要

他汀类药物激活磷脂酰肌醇-3-激酶,后者激活胞外5'-核苷酸酶并使3-磷酸肌醇依赖性激酶-1(PDK-1)磷酸化。磷酸化的(P-)PDK-1使Akt磷酸化,Akt进而使内皮型一氧化氮合酶(eNOS)磷酸化。我们探究了腺苷受体(A(1)、A(2A)、A(2B)或A(3)受体)的阻断是否能减弱阿托伐他汀(ATV)对Akt和eNOS的诱导作用,以及细胞外信号调节激酶1/2(ERK1/2)是否参与ATV对Akt和eNOS的调节。在方案1中,小鼠腹腔注射ATV、茶碱(TH)、ATV + TH或赋形剂。在方案2中,小鼠腹腔注射ATV、U0126(一种ERK1/2抑制剂)、ATV + U0126或赋形剂;8小时后,通过免疫印迹分析评估心脏。在方案3中,小鼠单独腹腔注射ATV或与8-磺基苯基茶碱(SPT)一起注射;注射后1、3和6小时,通过免疫印迹分析评估心脏。在方案4中,小鼠单独腹腔注射ATV或与SPT、1,3-二丙基-8-环戊基黄嘌呤(DPCPX)、1,3,7-三甲基-8-(3-氯苯乙烯基)黄嘌呤(CSC)、咯嗪或MRS-1523一起注射;注射后3小时,通过免疫印迹分析评估心脏。ATV增加了P-ERK、P-PDK-1、Ser(473) P-Akt、Thr(308) P-Akt和P-eNOS的水平。TH阻断了ATV诱导的P-ERK、Ser(473) P-Akt、Thr(308) P-Akt和P-eNOS水平的升高,但不影响ATV对P-PDK-1的诱导。U0126阻断了ATV对Ser(473) P-Akt和Thr(308) P-Akt的诱导,同时减弱了对P-eNOS的诱导。注射后3小时和6小时可检测到P-ERK、Ser(473) P-Akt和P-eNOS增加,但1小时时未检测到。DPCPX、CSC和咯嗪部分阻断了ATV对P-ERK、Ser(473) P-Akt和P-eNOS的诱导。总之,阻断腺苷A(1)、A(2A)和A(2B)受体而非A(3)受体可抑制他汀类药物对Akt和eNOS的诱导。腺苷是他汀类药物激活ERK1/2所必需的,这导致了Akt和eNOS的磷酸化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验